Medicare Enrolled

Dr. Mary Beasley, MD

Pathology - Anatomic · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1 GUSTAVE L LEVY PL, New York, NY 10029
2122415307
In practice since 2007 (19 years)
NPI: 1306067186 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beasley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beasley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beasley

Dr. Mary Beasley is a pathology - anatomic specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Beasley performed 1,527 Medicare services across 914 unique beneficiaries.

Between the years covered by Open Payments, Dr. Beasley received a total of $46,702 from 8 pharmaceutical and/or device companies across 40 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beasley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in NY $46,702 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,527
Medicare services
Top 37% in NY for pathology - anatomic
914
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
308 $24 $188
Moderately high complexity pathology tissue examination
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation.
203 $70 $607
Limited pathology tissue examination
A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis.
201 $4 $40
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
163 $29 $225
Special tissue stain and interpretation
A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings.
135 $10 $155
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
131 $10 $110
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
109 $35 $221
Special stain test for organisms
A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results.
106 $22 $175
Intraoperative pathology examination, first tissue block
A pathologist examines a tissue sample removed during surgery to provide a preliminary diagnosis. This test is performed on the first tissue block obtained from the procedure.
77 $53 $232
High complexity pathology tissue examination
A laboratory test where a pathologist examines tissue samples under a microscope using advanced techniques to analyze cellular details.
36 $124 $972
Tissue preparation to remove calcium
A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination.
24 $10 $58
Surgical pathology consultation on referred slides
A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples.
22 $86 $345
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
12 $62 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$46,702
Total received (2019-2024)
Avg $7,784/year across 6 years
Top 2% in NY for pathology - anatomic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
8
Companies
40
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,971 (62.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,731 (38.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,095
2023
$10,043
2022
$19,223
2021
$3,328
2020
$2,083
2019
$8,930

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,095
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$20,369
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,463
GENZYME CORPORATION
$6,226
AstraZeneca UK Limited
$5,142
AbbVie Inc.
$3,817
Eli Lilly and Company
$2,790
Janssen Global Services, LLC
$1,760
AstraZeneca Pharmaceuticals LP
$135
Top 3 companies account for 70.8% of all-time payments
Associated products mentioned in payments ›
OFEV
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for pathology - anatomic in NY.

Looking for a pathology - anatomic specialist in New York?
Compare pathology - anatomics in the New York area by procedure volume, costs, and industry payment transparency.
Browse pathology - anatomics nearby

Geographic Context

Pathology - anatomics within 10 mi
609
Per 100K population
37.4
County median income
$104,553
Nearest hospital
MOUNT SINAI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beasley is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 2% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beasley experienced with tissue staining for diagnosis, additional?
Based on Medicare claims data, Dr. Beasley performed 308 tissue staining for diagnosis, additional services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beasley receive payments from pharmaceutical companies?
Yes. Dr. Beasley received a total of $46,702 from 8 companies across 40 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beasley's costs compare to other pathology - anatomics in New York?
Dr. Beasley's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beasley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →